Market Cap (In JPY)
6.01 Billion
Revenue (In JPY)
316.81 Million
Net Income (In JPY)
-1.13 Billion
Avg. Volume
589.25 Thousand
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 121.0-353.0
- PE
- -6.24
- EPS
- -22.28
- Beta Value
- 0.0
- ISIN
- JP3759560000
- CUSIP
- -
- CIK
- -
- Shares
- 43276764.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Koji Tamada M.D., Ph.D.
- Employee Count
- -
- Website
- https://www.noile-immune.com
- Ipo Date
- 2023-06-28
- Details
- Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.
More Stocks
-
AIWAlmawave S.p.A.
AIW
-
0A23Phreesia, Inc.
0A23
-
LSB
-
DFM
-
6498KITZ Corporation
6498
-
122990WiSoL CO.,LTD.
122990
-
HUMBLEHumble Group AB (publ)
HUMBLE
-
090710Hyulim ROBOT Co.,Ltd.
090710